These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 12778475

  • 21. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N, Mukherjee S, Das L, Das PK.
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [Abstract] [Full Text] [Related]

  • 22. Differential production of immunoglobulin classes and subclasses by mucosal-type human B-lymphocytes exposed in vitro to CpG oligodeoxynucleotides.
    Cognasse F, Acquart S, Beniguel L, Sabido O, Chavarin P, Genin C, Garraud O.
    Clin Chem Lab Med; 2005 Jun; 43(1):22-31. PubMed ID: 15653438
    [Abstract] [Full Text] [Related]

  • 23. [Toll-like receptor 9 in cpG oligodeoxynucleotides-induced species-specific immune responses].
    Li N, Fan XG, Tang SE, Zhu C.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):533-5. PubMed ID: 16320582
    [Abstract] [Full Text] [Related]

  • 24. The human B cell response to IL-13 is dependent on cellular phenotype as well as mode of activation.
    Ford D, Sheehan C, Girasole C, Priester R, Kouttab N, Tigges J, King TC, Luciani A, Morgan JW, Maizel AL.
    J Immunol; 1999 Sep 15; 163(6):3185-93. PubMed ID: 10477586
    [Abstract] [Full Text] [Related]

  • 25. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
    Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, Giese T, Engelmann H, Endres S, Krieg AM, Hartmann G.
    Eur J Immunol; 2001 Oct 15; 31(10):3026-37. PubMed ID: 11592079
    [Abstract] [Full Text] [Related]

  • 26. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide.
    Gürsel M, Verthelyi D, Gürsel I, Ishii KJ, Klinman DM.
    J Leukoc Biol; 2002 May 15; 71(5):813-20. PubMed ID: 11994506
    [Abstract] [Full Text] [Related]

  • 27. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.
    Zhang Y, Shoda LK, Brayton KA, Estes DM, Palmer GH, Brown WC.
    J Interferon Cytokine Res; 2001 Oct 15; 21(10):871-81. PubMed ID: 11711000
    [Abstract] [Full Text] [Related]

  • 28. CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway.
    Xu W, Tamura T, Takatsu K.
    Int Immunopharmacol; 2008 Feb 15; 8(2):351-61. PubMed ID: 18182251
    [Abstract] [Full Text] [Related]

  • 29. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
    Brummel R, Roberts TL, Stacey KJ, Lenert P.
    Eur J Immunol; 2006 Jul 15; 36(7):1951-62. PubMed ID: 16791898
    [Abstract] [Full Text] [Related]

  • 30. Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors.
    Daftarian P, Song GY, Ali S, Faynsod M, Longmate J, Diamond DJ, Ellenhorn JD.
    Cancer Res; 2004 Aug 01; 64(15):5407-14. PubMed ID: 15289349
    [Abstract] [Full Text] [Related]

  • 31. Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19.
    Hoene V, Peiser M, Wanner R.
    J Leukoc Biol; 2006 Dec 01; 80(6):1328-36. PubMed ID: 17000899
    [Abstract] [Full Text] [Related]

  • 32. Bidirectional regulation of human B cell responses by CD40-CD40 ligand interactions.
    Miyashita T, McIlraith MJ, Grammer AC, Miura Y, Attrep JF, Shimaoka Y, Lipsky PE.
    J Immunol; 1997 May 15; 158(10):4620-33. PubMed ID: 9144474
    [Abstract] [Full Text] [Related]

  • 33. An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body.
    Cao Y, Gordic M, Kobold S, Lajmi N, Meyer S, Bartels K, Hildebrandt Y, Luetkens T, Ihloff AS, Kröger N, Bokemeyer C, Atanackovic D.
    J Immunol Methods; 2010 Jun 30; 358(1-2):56-65. PubMed ID: 20302874
    [Abstract] [Full Text] [Related]

  • 34. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.
    Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M, Wader T, Tluk S, Liu M, Davis HL, Krieg AM.
    Eur J Immunol; 2004 Jan 30; 34(1):251-62. PubMed ID: 14971051
    [Abstract] [Full Text] [Related]

  • 35. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration.
    Heikenwalder M, Polymenidou M, Junt T, Sigurdson C, Wagner H, Akira S, Zinkernagel R, Aguzzi A.
    Nat Med; 2004 Feb 30; 10(2):187-92. PubMed ID: 14745443
    [Abstract] [Full Text] [Related]

  • 36. Toll-like receptor 9 mediates CpG-DNA signaling.
    Chuang TH, Lee J, Kline L, Mathison JC, Ulevitch RJ.
    J Leukoc Biol; 2002 Mar 30; 71(3):538-44. PubMed ID: 11867692
    [Abstract] [Full Text] [Related]

  • 37. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
    Roda JM, Parihar R, Carson WE.
    J Immunol; 2005 Aug 01; 175(3):1619-27. PubMed ID: 16034101
    [Abstract] [Full Text] [Related]

  • 38. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells.
    Zhu FG, Marshall JS.
    J Leukoc Biol; 2001 Feb 01; 69(2):253-62. PubMed ID: 11272276
    [Abstract] [Full Text] [Related]

  • 39. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
    Harp CT, Lovett-Racke AE, Racke MK, Frohman EM, Monson NL.
    Clin Immunol; 2008 Sep 01; 128(3):382-91. PubMed ID: 18599355
    [Abstract] [Full Text] [Related]

  • 40. CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens.
    Jahrsdörfer B, Hartmann G, Racila E, Jackson W, Mühlenhoff L, Meinhardt G, Endres S, Link BK, Krieg AM, Weiner GJ.
    J Leukoc Biol; 2001 Jan 01; 69(1):81-8. PubMed ID: 11200072
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.